Radiolabeled tirofiban – a potential radiopharmaceutical for detection of deep venous thrombosis

References

• FusterVBadimonLBadimonJJChesebroJHThe pathogenesis of coronary artery disease and the acute coronary syndromesN Engl J Med199232642422501727977
   PubMed Web of Science ®Google Scholar
• JagroopIAMikhailidisDPThe effect of Tirofiban on fibrinogen/agonist-induced platelet shape change and aggregationClin Appl Thromb Hemost200814329530218445610
   PubMed Web of Science ®Google Scholar
• ChristieDJAvariTCarringtonLRPlatelet Function Testing by Aggregometry: Approved GuidelineCLSI Guideline H58-A1-56238-683-2Clinical and Laboratory Standards InstituteWayne, PA2008
   Google Scholar
• HaywardCPMoffatKARabADevelopment of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometryAm J Clin Pathol201013495596321088160
   PubMed Web of Science ®Google Scholar
• LeslieMCell biology. Beyond clotting: the powers of plateletsScience2010328597856256420430990
   PubMed Web of Science ®Google Scholar
• BrassLUnderstanding and evaluating platelet functionHematology Am Soc Hematol Educ Program2010201038739621239824
   PubMed Web of Science ®Google Scholar
• PickerSMIn-vitro assessment of platelet functionTransfus Apheresis Sci2011443305319
   PubMed Web of Science ®Google Scholar
• GiordanoAD’AngelilloARomanoSTirofiban induces VEGF production and stimulates migration and proliferation of endothelial cellsVascul Pharmacol2014612–3637124751361
   PubMed Web of Science ®Google Scholar
• HashemzadehMFurukawaMGoldsberrySMovahedMRChemical structures and mode of action of intravenous glycoprotein IIb/IIIa receptor blockers: a reviewExp Clin Cardiol200813419219719343166
   PubMedGoogle Scholar
• JayasunderaTGFeldmanDNMarmurJDTirofiban-induced coronary thrombosisJ Invas Cardiol1999113138140
   PubMed Web of Science ®Google Scholar
• LannettaLPudduPECuturelloDSaladiniAPellicanoMSchiaritiMIs there still a role for glycoprotein IIb/IIIa antagonists in acute coronary syndromes?Cardiol Res20134117
   PubMedGoogle Scholar
• KingSShortMHarmonCGlycoprotein IIb/IIIa inhibitors: the resurgence of tirofibanVascul Pharmacol201678101626187354
   PubMed Web of Science ®Google Scholar
• BruntonLLLazoJSParkerKLGoodman and Gilman’s, The Pharmacological Basis of Therapeutics11th edNew YorkThe McGraw Hill Co2006
   Google Scholar
• KumarAHerrmannHCTirofiban: an investigational platelet glycoprotein IIb/IIIa receptor antagonistExpert Opin Investig Drugs19976912571267
   PubMedGoogle Scholar
• AnonTirofiban hydrochlorideDrugs Future199520897901
   Google Scholar
• http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20912lbl.pdfAccessed October 24, 2014
   Google Scholar
• Medicure PharmaAggrastat (Tirofiban Hydrochloride) Injection Premixed and Injection Prescribing InformationSomerset, NJMedicure Pharma2007
   Google Scholar
• Darkovska SerafimovskaMJanevik-IvanovskaEArsova-SarafinovskaZDjorgoskiIUgresicNDevelopment and validation of reverse phase high performance liquid chromatographic method for determination of tirofiban in serumInt J Pharm201444115120
   Google Scholar
• KulkarniSDopheideSMYapCLA revised model of platelet aggregationJ Clin Invest2000105678379110727447
   PubMed Web of Science ®Google Scholar
• SmithJWSteinhublSRLincoffAMRapid platelet-function assay – an automated and quantitative cartridge-based methodCirculation19999956206259950658
   PubMed Web of Science ®Google Scholar
• HolmesMBKubbaniSTerrienCSobelBSchneiderDQuantification by flow cytometry of the efficacy and interindividual variation of platelet inhibition induced by treatment with tirofiban and abciximabCoron Artery Dis200112324525311352081
   PubMed Web of Science ®Google Scholar
• SimonDILiuCBGanzPA comparative study of light transmission aggregometry and automated bedside platelet function assay in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibrate, or tirofibanCatheter Cardiovasc Interv200152442543211285593
   PubMed Web of Science ®Google Scholar
• Lister-JamesJMauerAThrombus imaging with a technetium 99m labeled, activated platelet receptor binding peptideJ Nucl Med1996213207
   Google Scholar
• PearsonDALister-JamesJMcBrideWJThrombus imaging using technetium-99m-labeled high-potency GPIIb/IIIa receptor antagonists. Chemistry and initial biological studiesJ Med Chem1996397137213828691467
   PubMed Web of Science ®Google Scholar
• CallasJWFareedDDJA survey of animal models to develop new and novel antithrombotic agentsSasaharaAALoscalzoJLNew Therapeutic Agents in Thrombosis and ThrombolysisNew YorkMarcel Dekker1997928
   Google Scholar
• HerbertJMBernatAMaffrandJPImportance of platelets in experimental venous thrombosis in the ratBlood1992809228122861421399
   PubMed Web of Science ®Google Scholar
• BougieDWWilkerPRWuitschickEDAcute thrombocytopenia after treatment with Tirofiban or eptifibatide is associated with antibodies specific for ligandoccupied GPIIb/IIIaJ Am Soc Hematol2002100620712076
   Google Scholar
• HardoffRBraegelmannFZanzonicoPExternal imaging of atherosclerosis in rabbits using an 123 I-labeled syntetic peptide fragmentJ Clin Pharmacol19933311103910478300886
   PubMed Web of Science ®Google Scholar
• KonstantinidesSTorbickiAAgnelliGTask Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)ESC Guidelines on the diagnosis and management of acute pulmonary embolismEur Heart J201435433033306925173341
   PubMed Web of Science ®Google Scholar
• KearonCAklEComerotaAJAntithrombotic therapy for VTE diseaseChest20121412 supple419Se494S22315268
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Clinical ExcellenceVenous Thromboembolic Disease: the Management of Venous Thromboembolic Disease of Thrombophilia Testing. Clinical GuidelineMethods Evidence and RecommendationsLondon2012
   Google Scholar
• JanevicETadzerISTc-99m labelling of platelets using diethyldithiocarbamate or 2,5-dihydroxy-benzoic acidPeriod Biol198991409411
   Web of Science ®Google Scholar
• SchneiderDJAnti-platelet therapy: glycoprotein IIbIIIa antagonistsBr J Clin Pharmacol201172467268221906121
   PubMed Web of Science ®Google Scholar
• TrajkovskiRMilenkovVDukovskiRJanevicETadžerISObeležavanje humanih trombocita sa dietill-ditiokarbamat Tc-99m (DDC)Bilten Hemat Transf1989172125
   Google Scholar
• van RensburgWJRoodtJPLamprechtSMeiringSMBadenhorstPNTirofiban versus abciximab: tirofiban is administered at suboptimal dosages when evaluated in an arterial thrombosis model in non-human primatesClin Exp Med201212425726322219002
   PubMed Web of Science ®Google Scholar
• YeungJHolinstatMNewer agents in antiplatelet therapy: a reviewJ Blood Med20123334222792011
   PubMedGoogle Scholar
• DarkovskaSMJanevik-IvanovskaEUgresicNDjorgoskiIImaging of deep venous thrombosis using radioactive-labeled tirofibanBratisl Med J2015116106216266
   Google Scholar
• VickersSTheoharidesADArisonBIn vitro and in vivo studies on the metabolism of tirofibanDrug Metab Dispos199927111360136610534322
   PubMed Web of Science ®Google Scholar